Skip to content
    Font Size

    PSA Test Cuts Prostate Cancer Deaths -- at a Cost

    European PSA Study: Screen 936 Men, Save 1 Cancer Death

    European PSA Study vs. U.S. PSA Study

    The European findings are in contrast to those from the U.S. Prostate, Lung, Colorectal, and Ovarian (PLCO) study. Miller says the U.S. study "shows absolutely no indication of a benefit" even after 13 years of routine PSA screening.

    Miller, one of the PLCO investigators, is critical of the European study. In an editorial accompanying the Schroder report, he suggests that PSA-screened men were more likely to be treated for prostate cancer at academic centers, where they got more state-of-the-art treatment.

    And even though the screened men were less likely to die of prostate cancer, death from any cause was just as likely in screened as in unscreened men.

    Schroder says the PLCO study has its own flaws -- not least of which is that about half the men in the group that was supposed to be unscreened actually had a PSA test before the study began. This, he says, means that many men with hidden, aggressive cancers were never enrolled in that group.

    Indeed, in the European study, three-fourths of the screened men who died of prostate cancer had their disease detected on first screening.

    Both Schroder and Miller agree that while they complement each other in some ways, the two large PSA studies have many differences. These include:

    • European men were screened only once every four years (every two years in Sweden); U.S. men were screened every year.
    • In Europe, screened men got prostate biopsies when their PSA level was 3 ng/mL. In the U.S., the PSA cutoff was 4 ng/mL.
    • In the European study, 13% of screening tests were false positives (no cancer detected on biopsy). The false-positive rate in the U.S. study was 7%.
    • The European PSA study enrolled about twice as many men as the U.S. study.
    • Overdiagnosis rates were about 50% in the European trial, but 17% to 30% in the U.S. trial.

    The PSA Test: Advice to Men

    Despite their very different takes on the two PSA studies, Schroder and Miller are in remarkable agreement about the lessons men should take from them.

    Today on WebMD

    man with doctor
    Symptoms, risks, treatments
    man coughing
    Men shouldn’t ignore
    prostate cancer cells
    What does this diagnosis mean?
    doctor and male patient
    Is it worth it?
    cancer fighting foods
    15 Cancer Symptoms Men Ignore
    Prostate Enlarged
    Picture Of The Prostate
    Prostate Cancer Quiz
    screening tests for men
    Prostate Cancer Symptoms
    Vitamin D